Toxicology of Industrial Compounds

B.G.LAKE AND R.J.PRICE 237
STOTT, W.T., 1988, Chemically induced proliferation of peroxisomes:
implications for risk assessment, Regulatory Toxicology and Pharmacology, 8,
125–59.
TAKAGI, A., SAI, K., UMEMURA, T., HASEGAWA, R. and KUROKAWA, Y.,
1990, Significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats
following short-term exposure to the peroxisome proliferators di(2-ethylhexyl)
phthalate and di(2-ethylhexyl)adipate, Japanese Journal of Cancer Research,
81, 213–15.
THORNBER, C.W., 1979, Isosterism and molecular modification in drug design,
Chemical Society Reviews, 8, 563–80.
TUCKER, M.J. and ORTON, T.C., 1993, Toxicological studies in primates with
three fibrates, in Gibson, G. and Lake, B. (Eds) Peroxisomes: Biology and
Importance in Toxicology and Medicine, pp. 425–47, London: Taylor and
Francis.
VON DÄNIKEN, A., LUTZ, W.K. and SCHLATTER, C., 1981, Lack of covalent
binding to rat liver DNA of the hypolipidemic drugs clofibrate and fenofibrate,
Toxicology Letters, 7, 311–19.
VON DÄNIKEN, A., LUTZ, W.K., JÄCKH, R. and SCHLATTER, C., 1984,
Investi-gation of the potential for binding of di(2-ethylhexyl)phthalate (DEHP)
and di(2-ethylhexyl)adipate (DEHA) to liver DNA in vivo, Toxicology and
Applied Pharmacology, 73, 373–87.
WADA, N., MARSMAN, D.S. and POPP, J.A., 1992, Dose-related effects of
hepatocarcinogen, Wy-14,643 on peroxisomes and cell replication,
Fundamental and Applied Toxicology, 18, 149–54.
WEISBURGER, J.H., 1994, Does the Delaney Clause of the U.S. Food and Drug
Laws prevent human cancers? Fundamental and Applied Toxicology, 22, 483–
93.